Found: 29
Select item for more details and to access through your institution.
An ACVR1<sup>R375P</sup> pathogenic variant in two families with mild fibrodysplasia ossificans progressiva.
- Published in:
- American Journal of Medical Genetics. Part A, 2022, v. 188, n. 3, p. 806, doi. 10.1002/ajmg.a.62585
- By:
- Publication type:
- Article
Will rheumatologists ever pick up the arthroscope again?
- Published in:
- International Journal of Rheumatic Diseases, 2021, v. 24, n. 10, p. 1235, doi. 10.1111/1756-185X.14184
- By:
- Publication type:
- Article
Impact of standard of care treatments and disease variables on outcomes in systemic lupus erythematosus trials: analysis from the Lupus Foundation of America Collective Data Analysis Initiative.
- Published in:
- European Journal of Rheumatology, 2016, v. 3, n. 1, p. 13, doi. 10.5152/eurjrheum.2015.0048
- By:
- Publication type:
- Article
Utility of the Ultrasound Examination of the Hand and Wrist Joints in the Management of Established Rheumatoid Arthritis.
- Published in:
- Arthritis Care & Research, 2014, v. 66, n. 2, p. 236, doi. 10.1002/acr.22119
- By:
- Publication type:
- Article
Decreased live births in women with systemic lupus erythematosus.
- Published in:
- Arthritis Care & Research, 2011, v. 63, n. 7, p. 1068, doi. 10.1002/acr.20466
- By:
- Publication type:
- Article
The Effect of Combined Estrogen and Progesterone Hormone Replacement Therapy on Disease Activity in Systemic Lupus Erythematosus: A Randomized Trial.
- Published in:
- Annals of Internal Medicine, 2005, v. 142, n. 12, p. 953, doi. 10.7326/0003-4819-142-12_Part_1-200506210-00004
- By:
- Publication type:
- Article
Is It Time to Bring Back Knee Washout?
- Published in:
- Journal of Rheumatology, 2022, v. 49, n. 12, p. 1307, doi. 10.3899/jrheum.211132
- By:
- Publication type:
- Article
Arthroscopy in Rheumatology: Time for a New Look?
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Assessing disease activity in SLE patients during pregnancy.
- Published in:
- Lupus, 1999, v. 8, n. 8, p. 677, doi. 10.1191/096120399680411272
- By:
- Publication type:
- Article
Arthroscopy in rheumatology: where have we been? Where might we go?
- Published in:
- Rheumatology, 2021, v. 60, n. 2, p. 518, doi. 10.1093/rheumatology/keaa560
- By:
- Publication type:
- Article
086 Safety and efficacy of filgotinib in a phase 3 trial of patients with active rheumatoid arthritis and inadequate response or intolerance to biologic disease modifying anti-rheumatic drugs.
- Published in:
- 2019
- By:
- Publication type:
- Abstract
Clinical trial parameters that influence outcomes in lupus trials that use the systemic lupus erythematosus responder index.
- Published in:
- Rheumatology, 2018, v. 57, n. 1, p. 125, doi. 10.1093/rheumatology/kex368
- By:
- Publication type:
- Article
Epratuzumab for patients with moderate to severe flaring SLE: health-related quality of life outcomes and corticosteroid use in the randomized controlled ALLEVIATE trials and extension study SL0006.
- Published in:
- Rheumatology, 2014, v. 53, n. 3, p. 502, doi. 10.1093/rheumatology/ket378
- By:
- Publication type:
- Article
Efficacy and safety of epratuzumab in patients with moderate/severe flaring systemic lupus erythematosus: results from two randomized, double-blind, placebo-controlled, multicentre studies (ALLEVIATE) and follow-up.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Efficacy and safety of epratuzumab in patients with moderate/severe flaring systemic lupus erythematosus: results from two randomized, double-blind, placebo-controlled, multicentre studies (ALLEVIATE) and follow-up.
- Published in:
- Rheumatology, 2013, v. 52, n. 7, p. 1313, doi. 10.1093/rheumatology/ket129
- By:
- Publication type:
- Article
CXCL13: a novel biomarker of B-cell return following rituximab treatment and synovitis in patients with rheumatoid arthritis.
- Published in:
- Rheumatology, 2011, v. 50, n. 3, p. 603, doi. 10.1093/rheumatology/keq337
- By:
- Publication type:
- Article
A Multianalyte Assay Panel With Cell‐Bound Complement Activation Products Predicts Transition of Probable Lupus to American College of Rheumatology–Classified Lupus.
- Published in:
- ACR Open Rheumatology, 2021, v. 3, n. 2, p. 116, doi. 10.1002/acr2.11219
- By:
- Publication type:
- Article
Effect of Filgotinib vs Placebo on Clinical Response in Patients With Moderate to Severe Rheumatoid Arthritis Refractory to Disease-Modifying Antirheumatic Drug Therapy: The FINCH 2 Randomized Clinical Trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Complement Activation in Patients With Probable Systemic Lupus Erythematosus and Ability to Predict Progression to American College of Rheumatology–Classified Systemic Lupus Erythematosus.
- Published in:
- Arthritis & Rheumatology, 2020, v. 72, n. 1, p. 78, doi. 10.1002/art.41093
- By:
- Publication type:
- Article
Establishing Surrogate Kidney End Points for Lupus Nephritis Clinical Trials: Development and Validation of a Novel Approach to Predict Future Kidney Outcomes.
- Published in:
- Arthritis & Rheumatology, 2019, v. 71, n. 3, p. 411, doi. 10.1002/art.40724
- By:
- Publication type:
- Article
Brief Report: Longitudinal Patterns of Response to Standard of Care Therapy for Systemic Lupus Erythematosus: Implications for Clinical Trial Design.
- Published in:
- Arthritis & Rheumatology, 2017, v. 69, n. 4, p. 785, doi. 10.1002/art.40013
- By:
- Publication type:
- Article
Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials.
- Published in:
- Arthritis & Rheumatology, 2017, v. 69, n. 2, p. 362, doi. 10.1002/art.39856
- By:
- Publication type:
- Article
Anifrolumab, an Anti-Interferon-α Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus.
- Published in:
- Arthritis & Rheumatology, 2017, v. 69, n. 2, p. 376, doi. 10.1002/art.39962
- By:
- Publication type:
- Article
Longitudinal patterns and predictors of response to standard-of-care therapy in lupus nephritis: data from the Accelerating Medicines Partnership Lupus Network.
- Published in:
- Arthritis Research & Therapy, 2024, v. 26, n. 1, p. 1, doi. 10.1186/s13075-024-03275-z
- By:
- Publication type:
- Article
Calcium-containing crystals and osteoarthritis: Implications for the clinician.
- Published in:
- Current Rheumatology Reports, 2005, v. 7, n. 3, p. 213, doi. 10.1007/s11926-996-0042-2
- By:
- Publication type:
- Article
Treatment of the antiphospholipid antibody syndrome.
- Published in:
- Current Rheumatology Reports, 2004, v. 6, n. 6, p. 463, doi. 10.1007/s11926-004-0026-z
- By:
- Publication type:
- Article
Efficacy and safety of filgotinib in Japanese patients with refractory rheumatoid arthritis: Subgroup analyses of a global phase 3 study (FINCH 2).
- Published in:
- Modern Rheumatology, 2022, v. 32, n. 1, p. 59, doi. 10.1080/14397595.2020.1859675
- By:
- Publication type:
- Article
A Randomized, Placebo‐Controlled Phase III Extension Trial of the Long‐Term Safety and Tolerability of Anifrolumab in Active Systemic Lupus Erythematosus.
- Published in:
- Arthritis & Rheumatology, 2023, v. 75, n. 2, p. 253, doi. 10.1002/art.42392
- By:
- Publication type:
- Article
Epidemiology and outcomes of emergency department visits in systemic lupus erythematosus: Insights from the nationwide emergency department sample (NEDS).
- Published in:
- Lupus, 2023, v. 32, n. 14, p. 1646, doi. 10.1177/09612033231215381
- By:
- Publication type:
- Article